Corporate mission
Hubro Therapeutics is founded on its neo-peptide platform. The overarching goal of the company is to develop vaccines in both therapeutic and prophylactic settings based on this technology. Through further development of the capacities within its platform, the company seeks to develop strong candidates and explore these opportunities alone and/or in partnership with other institutions.
There is a wide scope of strategic and operational possibilities for the company, and it will tirelessly explore the most interesting paths, and create results which will improve survival for patients, provide better cancer care and deliver attractive returns to its shareholders.
